International Consensus on Use of Continuous Glucose Monitoring
Kinderkrankenhaus auf der Bult · Schneider Children's Medical Center · +34 more institutions
Abstract
Measurement of glycated hemoglobin (HbA1c) has been the traditional method for assessing glycemic control. However, it does not reflect intra- and interday glycemic excursions that may lead to acute events (such as hypoglycemia) or postprandial hyperglycemia, which have been linked to both microvascular and macrovascular complications. Continuous glucose monitoring (CGM), either from real-time use (rtCGM) or intermittently viewed (iCGM), addresses many of the limitations inherent in HbA1c testing and self-monitoring of blood glucose. Although both provide the means to move beyond the HbA1c measurement as the sole marker of glycemic control, standardized metrics for analyzing CGM data are lacking. Moreover,…
Citation impact
- FWCI
- 102.61
- Percentile
- 100%
- References
- 84
Authors
34Topics & keywords
- Medicine
- Continuous glucose monitoring
- Diabetes mellitus
- MEDLINE
- Intensive care medicine
- Endocrinology
- Type 1 diabetes
Funding
- ADAmerican Diabetes Association
- ALAbbott Laboratories
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- AAstraZeneca
- SSanofi
- LMLeona M. and Harry B. Helmsley Charitable Trust
- BBBigfoot Biomedical
- ICInsulet Corporation
- DDexcom
- JCJaeb Center for Health Research
- BHBayer HealthCare
- NNNovo Nordisk
- RDRoche Diabetes Care
- ADAbbott Diabetes Care